A barbiturate (a class of central nervous system [CNS] depressants with potent sedative and hypnotic properties) that is potentially addictive and lethal in overdose. For this reason, phenobarbital is seldom prescribed for treatment of anxiety or insomnia; however, it is still used as an anticonvulsant to control seizures.
Barbiturate used as a sedative to treat anxiety and as an anticonvulsant to treat some forms of epilepsy. Adverse effects include drowsiness, skin reactions, interaction with many other drugs, and possible development of dependence.
An anticonvulsant drug; a sedative. Phenobarbitai (Barbilixir, Solfoton) is one of the barbiturates that is used to treat seizures associated with epilepsy. It works by suppressing the spread of seizure activity in the brain. Phenobarbitai can also be used as a sedative because it acts throughout the central nervous system as a depressant.
A barbiturate drug used to treat insomnia and anxiety and as an anticonvulsant in the treatment of epilepsy. It is administered by mouth or injection; side-effects may include drowsiness and skin sensitivity reactions, and dependence may result from continued use.
Phenylbarbituric acid, a sedative, hypnotic, and anticonvulsant drug.
A barbiturate medication primarily employed as an anticonvulsant. Phenobarbital is often utilized alongside phenytoin for epilepsy treatment. Potential adverse reactions of the drug encompass sensations of drowsiness, lack of coordination, dizziness, heightened excitement, and confusion.